Form 8-K - Current report:
SEC Accession No. 0001437749-25-025827
Filing Date
2025-08-11
Accepted
2025-08-11 09:15:53
Documents
14
Period of Report
2025-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20250811_8k.htm   iXBRL 8-K 30718
2 EXHIBIT 99.1 ex_850763.htm EX-99.1 99541
  Complete submission text file 0001437749-25-025827.txt   288937

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20250811.xsd EX-101.SCH 4044
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20250811_def.xml EX-101.DEF 13417
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20250811_lab.xml EX-101.LAB 17617
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20250811_pre.xml EX-101.PRE 13394
16 EXTRACTED XBRL INSTANCE DOCUMENT bcda20250811_8k_htm.xml XML 4722
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)